U07.1
Conditions
Interventions
Group 1: Telemedical follow-up:
From the day of training at home by nurses, the patient measures their body weight, blood pressure, oxygen saturation, an ECG and enters their condition on the tablet
Sponsors
Charité - Universitätsmedizin Berlin CharitéCentrum 11 für Herz-Kreislauf-Medizin Arbeitsbereich Kardiovaskuläre Telemedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Hospitalization with detection of SARS-CoV-2 RNA (PCR) in naso-/oropharyngeal swab (hospital discharge letter available). 2.age of majority 3.written informed consent of the patient
Exclusion criteria
Exclusion criteria: 1.inability or unwillingness to measure daily vital signs (e.g., dementia, blindness, deafness, wheelchair use, inadequate German language skills, speech or voice disorders that interfere with voice analysis, limited informal self-determination) 2.participation in therapy studies (observational studies and registries are possible).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of unplanned clinical events (emergency telemedicine interventions, emergency department presentations, unplanned hospitalizations, death from any cause) as a composite endpoint during 1 year of telemedicine follow-up of hospitalized COVID-19- patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Days lost due to unplanned hospitalizations and death from any cause during one-year follow-up. 2.total mortality 3.number of unplanned hospitalizations 4.number of emergency department presentations 5.Number of telemedicine interventions for emergencies 6.changes in quality of life during follow-up 7.number of TMZ-contacts to the patient due to abnormal telemonitoring findings. 8.number of TMZ contacts to primary care physicians due to abnormal telemonitoring findings 9.adherence to telemonitoring | — |
Countries
Germany
Outcome results
None listed